These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34548142)

  • 21. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
    Zimmermann R; Kollan C; Ingiliz P; Mauss S; Schmidt D; Bremer V
    J Hepatol; 2017 Jul; 67(1):15-22. PubMed ID: 28189752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of hepatitis C virus nucleic acid testing positive donors in aviremic recipients with delayed direct-acting antiviral initiation.
    Hudson MR; Webb AR; Logan AT; Silverman A; Brueckner AJ
    Clin Transplant; 2021 Aug; 35(8):e14386. PubMed ID: 34132438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of HCV-infected organs in solid organ transplantation: An ethical challenge but plausible option.
    Nangia G; Borges K; Reddy KR
    J Viral Hepat; 2019 Dec; 26(12):1362-1371. PubMed ID: 31111619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding access to transplantation with hepatitis C-positive donors: A new perspective on an old issue.
    Kling CE; Limaye AP; Landis CS; Sibulesky L
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28130837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expanding Heart Transplant in the Era of Direct-Acting Antiviral Therapy for Hepatitis C.
    Schlendorf KH; Zalawadiya S; Shah AS; Perri R; Wigger M; Brinkley DM; Danter MR; Menachem JN; Punnoose LR; Balsara K; Sacks SB; Ooi H; Awad JA; Sandhaus E; Schwartz C; O'Dell H; Carver AB; Edmonds CL; Ruzevich-Scholl S; Lindenfeld J
    JAMA Cardiol; 2020 Feb; 5(2):167-174. PubMed ID: 31851352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCV-infected solid organ donors, direct-acting antivirals and the current challenges.
    Fabrizi F; Cerutti R; Silva M
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):7-14. PubMed ID: 31786966
    [No Abstract]   [Full Text] [Related]  

  • 27. Post-transplant survey to assess patient experiences with donor-derived HCV infection.
    Prakash K; Ramirez-Sanchez C; Ramirez SI; Logan C; Law N; Mekeel K; Pretorius V; Aslam S
    Transpl Infect Dis; 2020 Dec; 22(6):e13402. PubMed ID: 32634289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.
    Kapila N; Al-Khalloufi K; Bejarano PA; Vanatta JM; Zervos XB
    Am J Transplant; 2020 Feb; 20(2):600-605. PubMed ID: 31448549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Best practice recommendations for the use of hepatitis C viremic donor organs for hepatitis C virus naïve recipients.
    Stewart ZA; Shah SA; Rolls JA; Guarrera JV; Kandaswamy R; Axelrod DA
    Clin Transplant; 2021 Aug; 35(8):e14381. PubMed ID: 34086371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local specialty pharmacy and specialty clinic collaboration assists access to hepatitis C direct-acting antivirals.
    Zhu J; Hazen RJ; Joyce C; Delpino A; Kirkham HS; Strickland CD; Markes-Wilson S; Kim T; Kang M; Rubin RA; Stein LL
    J Am Pharm Assoc (2003); 2018; 58(1):89-93.e2. PubMed ID: 29154019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bypassing the bottleneck: intentional hepatitis C transmission with organ transplant.
    Durand CM; Chattergoon MA
    J Clin Invest; 2019 Jun; 129(8):3038-3040. PubMed ID: 31232703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of heart transplantation using hepatitis c-viremic donors: A systematic review with meta-analysis.
    Villegas-Galaviz J; Anderson E; Guglin M
    J Heart Lung Transplant; 2022 Apr; 41(4):538-549. PubMed ID: 35153130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of hepatitis C virus direct acting agents in liver transplant using very old donor grafts: a real-world single-center analysis.
    Ghinolfi D; Lai Q; Carrai P; Petruccelli S; Morelli M; Melandro F; Biancofiore G; De Simone P
    Updates Surg; 2022 Apr; 74(2):557-570. PubMed ID: 34807412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of Hepatitis C Virus-Positive Organs in Hepatitis C Virus-Negative Recipients.
    Kuntzen C; Bagha Z
    Clin Liver Dis; 2022 May; 26(2):291-312. PubMed ID: 35487612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commercial insurance delays direct-acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients.
    Torabi J; Rocca JP; Ajaimy M; Melvin J; Campbell A; Akalin E; Liriano LE; Azzi Y; Pynadath C; Greenstein SM; Le M; Goldstein DY; Fox AS; Carrero J; Weiss JM; Powell T; Racine AD; Reinus JF; Kinkhabwala MM; Graham JA
    Transpl Infect Dis; 2021 Feb; 23(1):e13449. PubMed ID: 32810315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C viraemic organs in solid organ transplantation.
    Weinfurtner K; Reddy KR
    J Hepatol; 2021 Mar; 74(3):716-733. PubMed ID: 33212088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C donor viremic cardiac transplantation: A practical approach.
    Morris KL; Adlam JP; Padanilam M; Patel A; Garcia-Cortes R; Chaudhry SP; Seasor E; Tompkins S; Hoefer C; Zanotti G; Walsh MN; Salerno C; Bochan M; Ravichandran A
    Clin Transplant; 2020 Jan; 34(1):e13764. PubMed ID: 31830339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-Center Experience in Pre-transplant Hepatitis C Virus (HCV) Treatment Among Living Donor Liver Transplant Candidates: Bridging the Direct-Acting Antivirals (DAA).
    Niranjan-Azadi AM; Kabacam G; Durand CM; Anjum S; Saberi B; Dagher NN; Philosophe B; Gurakar A
    Ann Transplant; 2017 Sep; 22():570-574. PubMed ID: 28935852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients.
    Aqel B; Wijarnpreecha K; Pungpapong S; Taner CB; Reddy K; Leise M; Mi L; Dickson RC
    J Hepatol; 2021 Apr; 74(4):873-880. PubMed ID: 33188903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal trends and impact of willingness to accept organs from donors with hepatitis C virus.
    Yuan Q; Cui H; Leya GA; Hong S; Roth EM; Sise ME; Bethea ED; Yeh H; Williams WW; Elias N
    Transpl Int; 2021 Dec; 34(12):2562-2569. PubMed ID: 34726801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.